Wyatt Technology Ranks as #4 in The Scientist’s 10th Annual Best Places to Work Survey
News Jun 04, 2012
Wyatt Technology Corporation has announced that it has been ranked the fourth best place to work in the scientific industry.
The accolade comes in the company’s 30th anniversary year, when the company is celebrating its unique, family focused approach to business.
The 10th Annual Best Places to Work in Industry survey by The Scientist has revealed that respondents ranked personal and scientific satisfaction as the most highly sought company trait, followed by high ethical standards.
Wyatt Technology is a high technology manufacturer of analytical instruments for biotechnology and pharmaceutical research and development offering expertise in macromolecular characterization since 1982.
Small companies such as Wyatt Technology have proven to be the most highly voted within the Top Ten companies to work for, due to their ability to nurture scientific excellence and provide high staff satisfaction.
With its dog-friendly workplace and clear focus on customer delight, Wyatt Technology has been recognized consistently by The Scientist for its dedication to maintaining a world-leading workforce with Best Places to Work awards in 2009, 2010 and 2011.
Dr. Wyatt, CEO, comments “We are delighted to hear that we have been recognized for the fourth consecutive year by The Scientist. We are very proud of our work environment and value each one of our expert staff. It is an especially exciting year for Wyatt Technology to win this accolade, as we are celebrating our 30th anniversary of expertise in macromolecular characterization instrumentation and software, and we plan to do it in style.”
Cannabinoids Are Easier on the Brain Than Booze, Study FindsNews
The research was published in the journal Addiction.READ MORE
Compound Prevents Neurological Damage, Shows Cognitive Benefits in Mouse model of Alzheimer’s DiseaseNews
Mouse nicotinamide riboside study shows potential for human research.READ MORE
Antidepressants: Molecular Research Provides New InsightNews
New molecular research shows how chemically diverse drugs used to treat depression and anxiety disorders interact with the protein that transports serotonin in the brain. The discovery could open the way for the development of additional forms of antidepressants collectively known as selective serotonin reuptake inhibitors, or SSRIs.READ MORE